The development and application of genetically engineered human serum albumin

Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 3

Abstract

Human serum albumin (HSA) is the most abundant protein in plasma and has many biological functions and clinical applications. An adequate and stable supply of functional HSA molecules that are easy to store and have a long half-life is still an unmet clinical need. Therefore, it is extremely necessary to develop alternative methods for large-scale production of HSA. Genetic engineering techniques can clone the HSA gene into microorganism, animal, and plant hosts for efficient expression, which provides new possibilities for the large-scale production of HSA. This article reviews the advances in recombinant HSA (rHSA) in different expression systems and the production of rHSA by xenogeneic animals such as pigs and cattle, in order to draw attention to the application potential of genetic engineering techniques in HSA production and the importance of rHSA in the biomedical field in future.

Authors and Affiliations

Yanhang GAO, Junqi NIU

Keywords

Related Articles

Influencing factors for recompensation in patients with decompensated hepatitis C cirrhosis

[Objective] To investigate the influencing factors for recompensation in patients with decompensated hepatitis C cirrhosis, and to establish a predictive model. [Methods] A total of 217 patients who were diagnosed with...

Effect of Xiayuxue Decoction against renal injury in mice with non-alcoholic fatty liver disease and its mechanism

[Objective] To investigate the effect of non-alcoholic fatty liver disease (NAFLD) induced by high-fat diet (HFD) on the kidneys of mice and the protective effect and mechanism of Xiayuxue Decoction. [Methods] A tota...

Research advances in the mechanism of action of nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome in autoimmune hepatitis

Autoimmune hepatitis (AIH) is chronic hepatitis caused by the attack of live cells by the immune system, and at present, the pathogenesis of AIH remains unclear. Inflammasomes are important components of innate immun...

The genetic association between nonalcoholic fatty liver disease and type 2 diabetes mellitus in different body mass index categories: A bidirectional Mendelian randomization study

[Objective] To investigate the genetic association between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) using bidirectional two-sample Mendelian randomization (MR), as well as the c...

Several issues in the surgical treatment of intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) ranks second among malignant liver tumors and has high malignancy and poor prognosis. Currently, surgical treatment remains the only potentially curative therapy for ICC, but wit...

Download PDF file
  • EP ID EP768483
  • DOI 10.12449/JCH250304
  • Views 10
  • Downloads 0

How To Cite

Yanhang GAO, Junqi NIU (2025). The development and application of genetically engineered human serum albumin. Journal of Clinical Hepatology, 41(3), -. https://www.europub.co.uk/articles/-A-768483